Abstract:BACKGROUND: Harmine has antitumor and antinociceptive effects, and inhibits human DNA topoisomerase. However, no detailed data are available on the mechanisms of action of harmine in hepatocellular carcinoma. This study aimed to investigate the effects of harmine on proliferation and apoptosis, and the underlying mechanisms in the human hepatocellular carcinoma cell line HepG2.METHODS: The proliferation of HepG2 cells was determined by the cell counting kit-8 (CCK-8) assay and the clone formation test. The morphology of HepG2 cells was examined using fluorescence microscopy after Hoechst 33258 staining. Annexin V/propidium iodide (PI) was used to analyze apoptosis and PI to analyze the cell cycle. Western blotting was used to assess expression of the apoptosis-regulated genes Bcl-2, Bax, Bcl-xl, Mcl-1, caspase-3, and caspase-9. Mitochondrial transmembrane potential (Psi(m)) was determined using JC-1.RESULTS: Harmine inhibited the proliferation of HepG2 cells in a dose-dependent manner. Hoechst 33258 staining revealed nuclear fragmentation and chromosomal condensation, cell shrinkage, and attachment loss in HepG2 cells treated with harmine. The percentage of the sub/G1 fraction was increased in a concentration-dependent manner, indicating apoptotic cell death. PI staining showed that harmine changed the cell cycle distribution, by decreasing the proportion of cells in G0/G1 and increasing the proportion in S and G2/M. Harmine induced apoptosis in a concentration-dependent manner, with rates of 20.0%, 32.7% and 64.9%, respectively. JC-1 revealed a decrease in Psi(m). Apoptosis of HepG2 cells was associated with caspase-3 and caspase-9 activation, down-regulation of Bcl-2, Mcl-1, and Bcl-xl, and no change in Bax.CONCLUSIONS: Harmine had an anti-proliferative effect in HepG2 cells by inducing apoptosis. Mitochondrial signal pathways were involved in the apoptosis. The cancer-specific selectivity shown in this study suggested that harmine is a promising novel drug for human hepatocellular carcinoma.

Harmine and its derivatives: an In-depth review of antitumor mechanisms and structure-activity relationship

Research progress on the antitumor effects of harmine

Synthesis and Structure–activity Relationships of Harmine Derivatives As Potential Antitumor Agents

Novel Harmine Derivatives for Tumor Targeted Therapy

Pharmacological effects of harmine and its derivatives: a review

Synthesis and Biological Evaluation of 1,2,7,9-Tetrasubstituted Harmine Derivatives As Potential Antitumor Agents

Synthesis and mechanisms of action of novel harmine derivatives as potential antitumor agents

Evaluation of therapeutic role of harmaline: in vitro cytotoxicity targeting nucleic acids

A Review on Mechanistic Insight of Plant Derived Anticancer Bioactive Phytocompounds and Their Structure Activity Relationship

Design of New Benzo[h]chromene Derivatives: Antitumor Activities and Structure-Activity Relationships of the 2,3-Positions and Fused Rings at the 2,3-Positions

Synthesis and biological evaluation of N(9)-substituted harmine derivatives as potential anticancer agents.

Synthesis, Molecular Docking and Antitumor Activity of New Dithiazoles

Structural Activity Relationship-based Medicinal perceptions of Pyrazoline derivatives as Anti-Cancer Agents: A Review

Heterocyclic Phytochemicals as Anticancer Agents

Design, Synthesis and Evaluation of Structurally Diverse Polycyclic Harmaline Scaffolds As Anticancer Agents

Structural Insights into N-heterocyclic Moieties as an Anticancer Agent against Hepatocellular Carcinoma: An Exhaustive Perspective

Anticancer potential and structure activity studies of purine and pyrimidine derivatives: an updated review

Harmines Inhibit Cancer Cell Growth Through Coordinated Activation of Apoptosis and Inhibition of Autophagy.

Anti-Tumor Activity of Indole: A Review

Roles of Natural Compounds from Medicinal Plants in Cancer Treatment: Structure and Mode of Action at Molecular Level

Harmine Induces Apoptosis in HepG2 Cells Via Mitochondrial Signaling Pathway